Αρχική World News Clinical Benefit of Pembrolizumab in Patients with Previously Treated Advanced Clear Cell... World News Clinical Benefit of Pembrolizumab in Patients with Previously Treated Advanced Clear Cell Gynaecological Cancers Από Ogkologos - 4 Μαρτίου, 2025 953 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACOCC study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR A PET-based, pCR-adapted Chemotherapy De-escalation Strategy Associated with an Excellent 3-year... 5 Απριλίου, 2024 FDA Approves Entrectinib Based on Tumor Genetics Rather Than Cancer Type 17 Σεπτεμβρίου, 2019 Exceptional Response Rates and Survival Among Patients with POLE/D1 Proofreading Deficient... 31 Μαΐου, 2024 What to Do When You Are Diagnosed With Cancer During Pregnancy 19 Ιανουαρίου, 2021 Φόρτωση περισσοτέρων HOT NEWS Can Artificial Intelligence Help See Cancer in New, and Better, Ways? Androgen Receptor May Explain Sex Differences in Melanoma Treatment Response EMA Recommends Granting a Marketing Authorisation for Catumaxomab Spotlight On: Pelvic Physical Therapists in Cancer Care